MENÚ

PMSDDS 2025

CureSHANK 2nd Annual Phelan-McDermid Syndrome Drug Development Symposium

Parc de Recerca Biomèdica Barcelona / June 26-27

cureshank

Organized by

Sponsored by

Speakers

Norma Alhambra
President of the Spanish Phelan-McDermid Syndrome Association

Elizabeth Berry-Kravis, MD, PhD
Professor, Departments of Pediatrics, Neurological Sciences, Anatomy and Cell Biology
Director, RUSH Pediatric Neurosciences F.A.S.T. Center for Translational Research, Rush University Medical Center, Chicago, USA

Catalina Betancur, MD, PhD
Director of Research, INSERM, CNRS, Sorbonne University, Paris, France
Chair, Scientific Advisory Board, Spanish Phelan-McDermid Syndrome Association

Geraline Bliss, MS
Founder and President – CureSHANK

Tobias Böckers, MD, PhD
Neuroscientist – Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany

Federico Bolognani, MD, PhD
Chief Medical Officer and co-Founder, Newleos Therapeutics

Thomas Bourgeron, PhD
Institut Pasteur, Paris, France

Joseph Buxbaum, PhD
Professor of Psychiatry, Neuroscience and Genetics
Director of the Seaver Autism Center for Research and Treatment
Icahn School of Medicine at Mount Sinai, New York, USA

Jordi Fàbrega
Co-Founder and CEO at Connecta Therapeutics, Barcelona, Spain

Ricardo Fernandes, MD, PhD
Chief Medical Officer, conect4children-Stichting, Utrecht, Netherlands

Dan Gallo, PhD
Clinical development and medical affairs, Jaguar Gene Therapy, Chicago, USA

Ayan Ghoshal, PhD
Special Adviser to CureSHANK, Cambridge, Massachusetts, USA

Tom Giles
PMS parent

Janya Grainok, PhD
Chief Discovery Officer, PYC Therapeutics, Perth, Australia

Katie Greed
PMS parent

Kendra Hegedus, RN
PMS parent

Eric Hoffman, PhD
CureSHANK Advisor

Alex Kolevzon, MD
Professor of Child and Adolescent Psychiatry
Clinical Director of the Seaver Autism Center for Research and Treatment
Icahn School of Medicine at Mount Sinai, New York, USA

April Levin, MD
Boston Children’s Hospital, Boston, USA

Eva Loth, PhD
King’s College London, Londo, England

Ana Mingorance, PhD
Chief of Translational Science – CureSHANK

Ciara Molloy, PhD
Senior Research Fellow, Trinity College, Dublin, Ireland 
Research Associate, King’s College London, London, UK

Joe Nolan, MBA
CEO, Jaguar Gene Therapy, Chicago, USA

Antonio M. Persico, MD
University of Modena and Reggio Emilia, Italy

Nuno Ribeiro Palha, PhD
Research Project Leader, Neurology R&D, Servier, France

Sandra Robert
PMS parent

Michael Schön, MD
Neuroscientist – Institute for Anatomy and Cell Biology, Ulm University
Chair of the European PMS Research Consortium

Morgan Sheng, PhD
The Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research,
USA

Andre Strydom, MRCPsych, MSc, PhD
King´s College London, Londo, England

Jordi Xaus
Chief Scientific Officer, Oryzon, Barcelona, Spain

Silvia Zaragoza Domingo, PhD
Neuropsychological Research Organization S.L. (Neuropsynchro). Barcelona, Spain